Precision medicine is transforming the field of medical devices. How can engineers, investors, clinicians, and medical device professionals anticipate the future? Our June symposium brings Bay Area stakeholders together to share insights and discuss how entrepreneurs can bring new technologies to market for the benefit of patients.
Check out the speaker lineup below!
Reg Kelly, PhD, Director, QB3 and Christine Leong Connors, Managing Director, JP Morgan Chase
1:45-2:10 "The Transformation of Medicine by Next Generation Sequencing"
Richard Klausner, MD, Senior Vice President & Chief Medical Officer, Illumina
2:10-2:35 "Triple-Aiming at Coronary Disease: Bringing Software and Big Data to Bear on a #1 Killer"
Campbell Rogers, MD, CMO, HeartFlow
3:00-3:25 "Devices to Help Patients Unlearn Neuropsychiatric Conditions"
Edward Chang, MD, Associate Professor in Residence of Neurological Surgery and Physiology, UCSF
3:25-3:50 "3D Bio-Printing: Enabling Functional, Architecturally Correct Human Tissues for Research and Treatment"
Eric David, MD, JD, Chief Strategy Officer, Organovo
4:20-4:25 Presentation of the Rosenman Innovation Awards
4:25-5:25 Panel discussion: "Technologies of Interest to Investors in the Near Future"
Moderated by Casey McGlynn, Partner, WSGR
Zach Bogue, Co-Managing Partner, Data Collective
Juan-Pablo Mas, Partner, Action Potential Venture Capital
Bruce Rosengard, MD, FRCS, Chief Technology Officer, Global Surgery, Johnson & Johnson